Refresh

Akums Drugs & Pharmaceuticals Ltd. - Research Center

544222 AKUMS Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23
Income

Operating income

1,286.83
Expenses

Material consumed

805.05

Manufacturing expenses

42.04

Personnel expenses

147.30

Selling expenses

-

Adminstrative expenses

50.57

Expenses capitalised

-

Cost of sales

1,044.95

Operating profit

241.88

Other recurring income

96.15

Adjusted PBDIT

338.03

Financial expenses

13.18

Depreciation

30.00

Other write offs

-

Adjusted PBT

294.85

Tax charges

24.89

Adjusted PAT

269.96

Non recurring items

-144.53

Other non cash adjustments

-

Reported net profit

125.43

Earnigs before appropriation

476.79

Equity dividend

-

Preference dividend

-

Dividend tax

-

Retained earnings

476.79
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com